hospital of Hvidovre
Hvidovre, 2650, Denmark
NCT Number: NCT04322825
The objective of this study was to examine the effect on spasticity and function of multifocal transcutaneous electrical stimulation incorporated in a 2-piece (Mollii) suit.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Interventional
Not applicable
Hvidovre, 2650, Denmark
In this prospective cohort study, the participants (children with predominantly spastic CP, GFMCS 3-5) wore the suit for 1 hour every second day for 24 weeks. The investigators evaluated level of spasticity using the modified Ashworth scale (MAS) and other related measures before initiation, after 4, 12, and 24 weeks. Two motor related smart goals were defined and evaluated by the goal attainment scale (GAS). GMFM-66 and posture and postural ability scale (PPAS) were performed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
trans cutaneous electric stimulation,
Time frame: 24 weeks
spasticity evaluation from 0 (best) to 4 (worst) in modified ashworth scale
Time frame: 24 weeks
smart goals from -2 (worst) to +2 (best)
Hvidovre University Hospital
Other
Mollii - Personalized Suit for Treatment of Spasticity, GFMCS3-5
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04904094
Brain Damage, Chronic, Brain Diseases
Leuven, Belgium
View Trial DetailsNCT01147653
Brain Damage, Chronic, Brain Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07316985
Brain Damage, Chronic, Brain Diseases
Binzhou, Shandong, China
View Trial DetailsNCT07251751
Brain Damage, Chronic, Brain Diseases
Shibīn al Kawm, Monoufia, Egypt
View Trial Details